Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joëlle Monnet
Safety of Adalimumab Biosimilar MSB11022 (Acetate-Buffered Formulation) in Patients With Moderately-To-Severely Active Rheumatoid Arthritis
Clinical Rheumatology
Medicine
Rheumatology
Related publications
OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis
AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis
Fri0087 Efficacy, Safety, and Immunogenicity Results of the Switch From Reference Adalimumab (Refadl) to Sandoz Biosimilar Adalimumab (Gp2017, SDZ-Adl) From Admyra Phase 3 Study in Patients With Moderate-To-Severe Rheumatoid Arthritis (Ra)
Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis
Arthritis Research & Therapy
Rheumatoid Arthritis-Associated Uveitis Treated With Adalimumab
Klinika Oczna
Medicine
Ophthalmology
Long-Term Treatment of Rheumatoid Arthritis With Adalimumab
Open Access Rheumatology: Research and Reviews
Rheumatology
Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis
New England Journal of Medicine
Medicine
Lethality of Patients With Rheumatoid Arthritis Depending on Adalimumab Administration: Imitation Modeling
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
